-
EP2090589
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2090589
| EP2090589 - Albumin-fused Kunitz domain peptides [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 29.11.2013 Database last updated on 03.09.2024 | Most recent event Tooltip | 29.11.2013 | Application deemed to be withdrawn | published on 01.01.2014 [2014/01] | Applicant(s) | For all designated states Dyax Corp. 300 Technology Square Cambridge, MA 02139 / US | [2012/18] |
| Former [2010/27] | For all designated states Dyax Corp. 300 Technology Square Cambridge, MA 02139 / US | ||
| For all designated states Novozymes Biopharma DK A/S Krogshoejvej 36 2880 Bagsvaerd / DK | |||
| Former [2009/34] | For all designated states Dyax Corp. 300 Technology Square Cambridge, MA 02139 / US | ||
| For all designated states Novozymes Biopharma UK Limited Castle Court 59, Castle Boulevard Nottingham NG7 1FD / GB | Inventor(s) | 01 /
Ladner, Robert Charles 3827 Green Valley Road Ijamsville Maryland 21754 / US | 02 /
Ley, Arthur C. 122 Adena Road Newton Maryland 02465 / US | 03 /
Sleep, Darrell 66 Ladybay Road Westbridgford Nottingham NG2 5DS / GB | 04 /
Hauser, Hans-Peter Feuerdornweg 6 35041 Marburg / DE | 05 /
Kee, Scott M. 218 Kathy Drive Bourbonnais Illinois 60914 / US | 06 /
Weimer, Thomas Richard-Wagner-Strasse 8 35075 Gladen Bach / DE | 07 /
Romberg, Val 1330 Old Schuykill Road Parkerford Pennsylvania 19457 / US | [2009/34] | Representative(s) | Potter Clarkson Chapel Quarter Mount Street Nottingham NG1 6HQ / GB | [N/P] |
| Former [2013/37] | Potter Clarkson LLP The Belgrave Centre Talbot Street Nottingham NG1 5GG / GB | ||
| Former [2010/27] | Bassett, Richard Simon, et al Potter Clarkson LLP Park View House 58 The Ropewalk Nottingham NG1 5DD / GB | ||
| Former [2009/34] | Bassett, Richard Simon Potter Clarkson LLP Park View House 58 The Ropewalk Nottingham NG1 5DD / GB | Application number, filing date | 09004575.8 | 07.02.2003 | [2009/34] | Priority number, date | US20020355547P | 07.02.2002 Original published format: US 355547 P | [2009/34] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2090589 | Date: | 19.08.2009 | Language: | EN | [2009/34] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 21.07.2009 | Classification | IPC: | C07K14/765, C07K14/81, C07K19/00, C12N15/14, C12N15/15, C12N15/62, C12N15/81 | [2009/34] | CPC: |
A61K38/39 (EP,US);
C07K14/765 (EP,KR,US);
A61K31/7088 (EP,US);
A61K38/38 (KR);
A61K39/0005 (EP,US);
A61K47/643 (EP,US);
A61K9/0019 (EP,US);
A61P1/00 (EP);
A61P1/04 (EP);
A61P1/18 (EP);
A61P11/00 (EP);
A61P11/06 (EP);
A61P17/00 (EP);
A61P17/02 (EP);
A61P17/06 (EP);
A61P19/02 (EP);
A61P19/04 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P3/12 (EP);
A61P31/10 (EP);
A61P31/18 (EP);
A61P35/00 (EP);
A61P37/02 (EP);
A61P37/04 (EP);
A61P39/02 (EP);
A61P7/00 (EP);
A61P7/04 (EP);
A61P7/10 (EP);
A61P9/00 (EP);
A61P9/02 (EP);
A61P9/10 (EP);
C07K14/005 (EP,US);
C07K14/47 (EP,US);
C07K14/475 (KR);
C07K14/78 (EP,US);
C07K14/8114 (EP,US);
C07K19/00 (KR);
C12N15/62 (EP,US);
C12Y301/26003 (EP,US);
A01K2217/05 (EP,US);
A61K2039/53 (EP,US);
A61K38/00 (EP,US);
A61K39/00 (EP,KR,US);
A61K48/00 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, SE, SI, SK, TR [2009/34] | Title | German: | Mit Albumin fusionierte Kunitz-Domänen-Peptide | [2009/34] | English: | Albumin-fused Kunitz domain peptides | [2009/34] | French: | Peptides de domaine de Kunitz fusionnées à l'albumine | [2009/34] | Examination procedure | 16.04.2009 | Examination requested [2009/34] | 23.02.2010 | Despatch of a communication from the examining division (Time limit: M06) | 10.08.2010 | Reply to a communication from the examining division | 11.03.2013 | Despatch of a communication from the examining division (Time limit: M04) | 23.07.2013 | Application deemed to be withdrawn, date of legal effect [2014/01] | 27.08.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2014/01] | Parent application(s) Tooltip | EP03737682.9 / EP1572930 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20030737682) is 21.11.2008 | Fees paid | Renewal fee | 16.04.2009 | Renewal fee patent year 03 | 16.04.2009 | Renewal fee patent year 04 | 16.04.2009 | Renewal fee patent year 05 | 16.04.2009 | Renewal fee patent year 06 | 16.04.2009 | Renewal fee patent year 07 | 16.02.2010 | Renewal fee patent year 08 | 15.02.2011 | Renewal fee patent year 09 | 15.02.2012 | Renewal fee patent year 10 | 27.02.2013 | Renewal fee patent year 11 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [DA]US5663143 (LEY ARTHUR CHARLES [US], et al); | [Y]US5795865 (MARKLAND WILLIAM [US], et al); | [Y]WO0147958 (ZYMOGENETICS INC [US]); | [Y]WO0179271 (PRINCIPIA PHARMACEUTICAL CORP [US], et al); | [Y]WO0179443 (HUMAN GENOME SCIENCES INC [US], et al) | by applicant | US4179337 | WO8605807 | EP0201239 | JPS6296086 | WO8704462 | EP0251744 | EP0258067 | US4736866 | EP0286424 | WO8900103 | EP0322094 | US4857467 | WO9001063 | EP0361991 | EP0387319 | WO9106657 | JPH0336516B | WO9404687 | WO9412650 | US5328470 | WO9523857 | WO9533833 | US5489743 | WO9629411 | US5576195 | US5602307 | US5637504 | US5641670 | WO9724445 | US5795865 | US5846818 | US5994125 | US6057287 | US6087473 | WO0044772 | WO0174980 | WO0179480 | US6333402 | US19470003555 | CA19700091311 | US20020355547 |